Pathophysiology of collateral development

Matthias Heil1, Wolfgang Schaper

  • 1Department of Experimental Cardiology, Max-Planck-Institute for Physiological and Clinical Research, Bad Nauheim, Germany.

Coronary Artery Disease
|October 20, 2004
PubMed

Insights

Arteriogenesis, the growth of collateral arteries, is vital for treating vascular diseases. Understanding its mechanisms, triggered by blood flow changes and involving cell interactions, is key to developing new therapies.

Area of Science:

  • Vascular Biology
  • Cardiovascular Research
  • Regenerative Medicine

Background:

  • Occlusive atherosclerotic vascular diseases often lead to collateral artery formation, a process known as arteriogenesis.
  • Arteriogenesis is hypothesized to involve the remodeling of pre-existing collateral anastomoses.
  • Altered blood flow conditions, specifically fluid shear stress, appear to be the primary triggers for this process.

Purpose of the Study:

  • To elucidate the mechanisms underlying arteriogenesis.
  • To identify key cellular and molecular events in collateral vessel growth.
  • To provide a foundation for developing therapeutic strategies for ischemic vascular diseases.

Main Methods:

  • Analysis of clinical observations in patients with vascular diseases.
  • Investigations using various animal models of arterial occlusion.
  • Examination of cellular activation, leukocyte recruitment, and vascular cell proliferation.

Main Results:

  • Early arteriogenesis involves endothelial cell activation and leukocyte recruitment to collateral vessels.
  • Leukocyte invasion into the perivascular space initiates a second phase of vascular cell proliferation.
  • Growth factors released by leukocytes drive vascular cell proliferation, accompanied by tissue and extracellular matrix remodeling.

Conclusions:

  • Arteriogenesis is a complex process initiated by hemodynamic changes and mediated by cellular interactions.
  • Understanding the sequential events in arteriogenesis is critical for therapeutic intervention.
  • Targeting arteriogenesis holds promise for treating ischemic vascular conditions.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Healing II: Complications01:24

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...